How are coverage, equity, and hesitancy related?

Coverage is the measured outcome; equity describes whether the chance to be vaccinated is fairly distributed; and hesitancy describes whether people who can be vaccinated choose to be. A low coverage figure can stem from inequitable access, from hesitancy, or from both.

Is vaccine hesitancy the same as being anti-vaccine?

No. Hesitancy describes a spectrum of delay or reluctance among people who may still accept some vaccines, and it is distinct from organised anti-vaccine opposition and from access barriers that prevent willing people from being vaccinated.

Vaccine Coverage, Equity, and Hesitancy

This area examines how fully immunization reaches a population and why uptake varies between groups. It brings together three interlocking concerns: how much of a target population is vaccinated (coverage), whether opportunities to be vaccinated are fairly distributed (access and equity), and whether people who can be vaccinated choose to be (hesitancy and confidence). Together these determine whether immunization programmes achieve the population-level protection that vaccines make biologically possible.

Find emne med PaperMindSnartFind papers & topics

Tools & resources

Hent slides

Learn & explore

VideoSnart

Definition

Vaccine coverage, equity, and hesitancy is the field concerned with the proportion of a target population that is immunized, the fairness of the distribution of immunization opportunities across social groups, and the attitudes and decisions that shape whether eligible people accept vaccination.

Scope

The area orients readers to the population and behavioural dimensions of immunization rather than the biology of vaccines or the technique of administration. It covers coverage measurement and gaps, the structural and social determinants of access, and the determinants of vaccine acceptance and refusal. It treats these as a reference framework for understanding why immunization programmes succeed or fall short, not as operational programme guidance.

Sub-topics

Core questions

What share of a target population is vaccinated, and how is that measured?
Which groups are systematically under-immunized, and why?
How do access barriers differ from attitudinal barriers to vaccination?
What distinguishes vaccine hesitancy from outright refusal or anti-vaccine activism?

Key concepts

Vaccination coverage
Coverage gaps and pockets of susceptibility
Herd immunity threshold
Vaccine hesitancy and confidence
Health equity and healthcare disparities
Social determinants of health
Access barriers versus attitudinal barriers

Mechanisms

Population immunity depends on the product of how many people are offered vaccination, how many of those can reach and use the service, and how many choose to accept it. Coverage measurement quantifies the end result; equity analysis identifies where in the pathway access fails for particular groups; and hesitancy research explains residual gaps that persist even where access is adequate. Larson and colleagues frame confidence as a dynamic, context-specific determinant of uptake, while Braveman situates many access gaps in structural and social conditions rather than individual choice. The same observed coverage gap can therefore arise from very different upstream causes, which is why the three lenses are analysed together.

Clinical relevance

Understanding coverage, equity, and hesitancy helps clinicians and public-health workers interpret why immunization rates differ across communities and recognise that under-vaccination may reflect access barriers, mistrust, or both. This entry describes the determinants of population uptake and is a reference framework; it does not prescribe individual immunization decisions or programme interventions.

Epidemiology

Routine childhood vaccination coverage rose substantially worldwide between 1980 and 2019 but remained uneven across and within countries, with persistent zero-dose and under-immunized populations concentrated in disadvantaged settings, as quantified by the Global Burden of Disease analysis. Confidence and hesitancy vary by place, vaccine, and time rather than being fixed traits of populations.

History

Concern with immunization coverage grew alongside the WHO Expanded Programme on Immunization from 1974, which set population coverage as an explicit programme goal. As average coverage rose, attention shifted to the residual gaps: equity analyses linked under-immunization to structural and social disadvantage, while the concept of vaccine hesitancy was consolidated in the 2010s as a distinct, measurable determinant of uptake separate from access.

Debates

Are coverage gaps mainly about access or about acceptance?: Some gaps reflect structural barriers to reaching services, while others persist where services are available but trust or motivation is low; distinguishing the two is contested and consequential because it points to different explanations, and conflating them can misattribute structural disadvantage to individual choice.

Key figures

Heidi Larson
Noni MacDonald
Paula Braveman

Seminal works

galles-2021
macdonald-2015
larson-2011

Frequently asked questions

How are coverage, equity, and hesitancy related?: Coverage is the measured outcome; equity describes whether the chance to be vaccinated is fairly distributed; and hesitancy describes whether people who can be vaccinated choose to be. A low coverage figure can stem from inequitable access, from hesitancy, or from both.
Is vaccine hesitancy the same as being anti-vaccine?: No. Hesitancy describes a spectrum of delay or reluctance among people who may still accept some vaccines, and it is distinct from organised anti-vaccine opposition and from access barriers that prevent willing people from being vaccinated.